https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Finerenone Approved by FDA for Treatment of Adults With Heart Failure

Finerenone Approved by FDA for Treatment of Adults With Heart Failure

Previously indicated to reduce the risk of end-stage kidney disease, cardiovascular death, and hospitalization for heart failure (HF) in chronic kidney disease, finerenone is now approved for patients with HF directly, offering a new treatment option.

administrator

Related Articles